[{"NetIncomeLoss_1_Q1_USD":-4441739.0,"GeneralAndAdministrativeExpense_1_Q1_USD":2136591.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":47282322.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":1.46,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":1016074.0,"Depreciation_1_Q1_USD":16780.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":4.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":1.52,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":71428.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":3036.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":2090031.0,"DividendsCommonStockCash_1_Q1_USD":0.0,"AssetsCurrent_0_Q1_USD":40999253.0,"AccruedVacationCurrent_0_Q1_USD":18487.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":70275.0,"CommonStockSharesIssued_0_Q1_shares":47371482.0,"Assets_0_Q1_USD":41161363.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":2.1,"ShareBasedCompensation_1_Q1_USD":345756.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":190020008.0,"ResearchAndDevelopmentExpense_1_Q1_USD":2228002.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":1.83,"PrepaidExpenseCurrent_0_Q1_USD":257081.0,"RestructuringCosts_1_Q1_USD":1238270.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.7416,"CommonStockValue_0_Q1_USD":4737.0,"OtherNonoperatingIncome_1_Q1_USD":1158088.0,"DepositsAssetsNoncurrent_0_Q1_USD":20000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":289152.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":129742.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q1_USD":1.29,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":149573.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":70279.0,"OtherAssetsCurrent_0_Q1_USD":1733655.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-4441739.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.005,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":39008517.0,"Liabilities_0_Q1_USD":2129202.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":600000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":37160.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q1_shares":41394.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":345756.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-3666697.0,"LiabilitiesCurrent_0_Q1_USD":2129202.0,"AccountsPayableCurrent_0_Q1_USD":458658.0,"NonoperatingIncomeExpense_1_Q1_USD":1161124.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":70279.0,"SeveranceCosts1_1_Q1_USD":1200000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":35633.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":563260.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":39008517.0,"RestructuringReserveCurrent_0_Q1_USD":1107205.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":78769.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":452814.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":104950.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":1859530.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommonStockSharesOutstanding_0_Q1_shares":47371482.0,"CurrentIncomeTaxExpenseBenefit_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":0.89,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"OperatingIncomeLoss_1_Q1_USD":-5602863.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":1.46,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":0.89,"LiabilitiesAndStockholdersEquity_0_Q1_USD":41161363.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":1126603.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":39171.0,"OperatingExpenses_1_Q1_USD":5602863.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.09,"StockholdersEquity_0_Q1_USD":39032161.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":4485326.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":2625796.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-150992584.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-3596418.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":220352.0,"Ticker":"AADI","CIK":"1422142","name":"AERPIO PHARMACEUTICALS, INC.","OfficialName":"Aadi Bioscience Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"339479977.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210517"}]